GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Harvard Bioscience
Harvard Bioscience produces a wide range of laboratory equipment for scientific research. Its stock price reflects the volume of funding for science and R&D. The chart tells the story of a stable business, albeit sensitive to budget cuts.
Share prices of companies in the market segment - Medical instruments
Harvard Bioscience manufactures and sells a wide range of scientific equipment and instruments for life sciences research. We've categorized it under "Medical Instruments." The chart below shows how the laboratory and research center supply sector is faring.
Broad Market Index - GURU.Markets
Harvard Bioscience is a manufacturer and distributor of a wide range of scientific equipment and instruments for life sciences research. As a key supplier, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it to Harvard Bioscience's performance to assess the state of this sector.
Change in the price of a company, segment, and market as a whole per day
HBIO - Daily change in the company's share price Harvard Bioscience
Harvard Bioscience, Inc.'s daily stock price fluctuations reflect volatility in the laboratory equipment sector. This metric demonstrates sensitivity to R&D spending by academic and pharmaceutical institutions.
Daily change in the price of a set of shares in a market segment - Medical instruments
Harvard Bioscience, Inc. is a manufacturer of biomedical research instruments. This chart shows the average daily volatility of the sector. Comparing it to HBIO, whose revenue depends on R&D budgets, helps evaluate it as a barometer of biotech innovation.
Daily change in the price of a broad market stock, index - GURU.Markets
Harvard Bioscience produces a wide range of equipment for biomedical research. Its business serves as a barometer of R&D activity in the pharmaceutical industry. Its stock price is an indicator of innovation activity, which influences the overall market environment.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Harvard Bioscience
Harvard Bioscience, Inc.'s year-over-year performance tells the story of its role as a provider of tools for biomedical research. Its 12-month market cap growth reflects demand for its products from academic and pharmaceutical labs, as well as its success in integrating acquired companies and streamlining its brand portfolio.
Annual dynamics of market capitalization of the market segment - Medical instruments
Harvard Bioscience, Inc. is a diversified provider of scientific research tools. This chart illustrates how its broad product portfolio, acquisition strategy, and reliance on academic and pharmaceutical R&D funding drive its robust growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Harvard Bioscience, a provider of tools for biomedical research, depends on generous R&D budgets. During periods of economic growth, when governments and corporations actively invest in science, the company's shares can outperform the market. Conversely, during periods of austerity, its performance can lag, reflecting reduced funding.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Harvard Bioscience
Harvard Bioscience produces scientific equipment for biomedical research. Its business depends on R&D spending from universities and pharmaceutical companies. Its monthly price fluctuations reflect these budget cycles and the demand for its products.
Monthly dynamics of market capitalization of the market segment - Medical instruments
This chart reflects the dynamics of the life sciences sector. For Harvard Bioscience, a laboratory equipment supplier, it provides context. Its movements reflect R&D spending by universities and pharmaceutical companies, which ensures stable demand.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Harvard Bioscience produces a wide range of laboratory equipment and instruments for biomedical research. Demand for its products depends on scientific funding. A chart of the overall market dynamics helps assess whether the stability of R&D spending makes Harvard Bioscience shares a defensive asset, less susceptible to general economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Harvard Bioscience
Harvard Bioscience, a manufacturer of biomedical research instruments, is responding to scientific news and R&D funding. Its weekly stock price reflects demand for its equipment from academic, pharmaceutical, and biotech labs conducting cutting-edge research.
Weekly dynamics of market capitalization of the market segment - Medical instruments
Harvard Bioscience, like other providers of biomedical research tools, reflects general trends in science funding. Pharmaceutical R&D budgets and government grants create a common demand for all players. The chart shows whether HBIO is moving in lockstep with the industry or whether its recent acquisitions are creating a different story.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Harvard Bioscience, as a healthcare company, can demonstrate defensive qualities by moving out of sync with the broader market. Demand for its scientific equipment is less dependent on economic cycles than that of industrial giants. The chart will help assess whether HBIO truly is a safe haven during periods of general market turbulence.
Market capitalization of the company, segment and market as a whole
HBIO - Market capitalization of the company Harvard Bioscience
Harvard Bioscience's market capitalization tells the story of supplying tools for scientific research. The company produces a wide range of laboratory equipment. Its price chart reflects how investors assess the level of scientific funding and the demand for its products from universities and pharmaceutical companies.
HBIO - Share of the company's market capitalization Harvard Bioscience within the market segment - Medical instruments
Harvard Bioscience manufactures and sells a wide range of scientific equipment for life science research. Its market share in laboratory instruments reflects its long history and recognizable brand. The chart shows the company's importance as a supplier to universities, pharmaceutical companies, and biotech companies.
Market capitalization of the market segment - Medical instruments
Harvard Bioscience produces a wide range of instruments and equipment for biomedical research. The chart below shows the market capitalization of the medical instruments sector. This represents the market that provides scientists with the equipment to make new discoveries.
Market capitalization of all companies included in a broad market index - GURU.Markets
Harvard Bioscience produces a wide range of laboratory equipment and instruments for the life sciences. Its market capitalization reflects its role as a supplier to scientists. The chart below shows the economic weight of companies creating instruments for biological research.
Book value capitalization of the company, segment and market as a whole
HBIO - Book value capitalization of the company Harvard Bioscience
Harvard Bioscience's material foundation is scientific equipment manufacturing. The company's book value reflects its factories, which produce preclinical research instruments such as syringe pumps and cell biology systems. The chart below shows how this laboratory supplier manages its diversified manufacturing portfolio.
HBIO - Share of the company's book capitalization Harvard Bioscience within the market segment - Medical instruments
Harvard Bioscience manufactures scientific instruments at its own facilities. These production sites are its main material asset. The S_BCap_Seg graph shows its share of the medical and laboratory instrument manufacturing infrastructure.
Market segment balance sheet capitalization - Medical instruments
Harvard Bioscience produces a wide range of equipment for biomedical research. It's a classic instrument-making business, requiring manufacturing capacity. The book value chart shows how investments in these tangible assets shape its position in the scientific market.
Book value of all companies included in the broad market index - GURU.Markets
Harvard Bioscience is a manufacturer of scientific instruments. The company's book value reflects its factories, where a wide range of laboratory equipment is created, from syringe pumps to cell biology systems. This is the material base that supplies scientists around the world with the tools for their research.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Harvard Bioscience
Harvard Bioscience produces a wide range of laboratory equipment for biomedical research. Its balance sheet reflects its production capacity. Its market capitalization is a valuation of its brands, distribution network, and stable demand from universities and pharmaceutical companies.
Market to book capitalization ratio in a market segment - Medical instruments
Harvard Bioscience produces a wide range of instruments for biomedical research. It is a classic supplier to the scientific community. The chart shows how the market values ββits brands and product portfolio relative to the book value of its manufacturing facilities.
Market to book capitalization ratio for the market as a whole
Harvard Bioscience produces a wide range of instruments and equipment for biomedical research. It is a classic manufacturing business serving science. Its value is determined by product quality and demand from laboratories. The chart shows how the market values ββthis important supplier to the scientific ecosystem.
Debts of the company, segment and market as a whole
HBIO - Company debts Harvard Bioscience
Harvard Bioscience, a manufacturer of biomedical research instruments, uses debt for strategic acquisitions and development. This chart shows how the company finances the acquisition of other companies with complementary technologies and invests in the creation of new lab equipment for its scientific clients.
Market segment debts - Medical instruments
Harvard Bioscience supplies a wide range of equipment and instruments for biomedical research to laboratories worldwide. This market is relatively stable, but requires constant innovation and investment in new product development. This chart shows how the company funds the development and production of its scientific products.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Harvard Bioscience
Harvard Bioscience manufactures and sells a wide range of biomedical research equipment. This chart shows the extent to which the company uses debt to finance its operations and growth. The level of debt may reflect investments in the development of new devices or a strategy to acquire other manufacturers in this niche.
Market segment debt to market segment book capitalization - Medical instruments
Harvard Bioscience produces a wide range of laboratory equipment for scientific research. This chart for the medical instruments sector shows how the industry as a whole funds innovation and production. This allows us to assess how the company's financial strategy aligns with industry norms and demand from the scientific community.
Debt to book value of all companies in the market
Harvard Bioscience produces and sells a wide range of instruments and equipment for biomedical research. Demand for its products depends on funding for science and R&D at pharmaceutical companies. The debt-to-book ratio chart shows overall investment activity, which determines research budgets.
P/E of the company, segment and market as a whole
P/E - Harvard Bioscience
Harvard Bioscience produces and sells a wide range of laboratory equipment and instruments for biomedical research. This chart reflects the volume of research funding. Its dynamics show how investors assess the demand for its products from universities, pharmaceutical companies, and biotech companies, which depends on their R&D budgets.
P/E of the market segment - Medical instruments
Harvard Bioscience represents the laboratory equipment sector. This chart shows the average price-to-earnings ratio for this industry. Comparing a company's price-to-earnings ratio to this metric helps understand whether the market considers its products and brand more or less valuable than those of other scientific research equipment providers.
P/E of the market as a whole
Harvard Bioscience produces a wide range of laboratory equipment and instruments used in scientific research. The company serves universities, pharmaceutical companies, and biotechnology companies. This chart reflects the state of the life sciences sector. The company's valuation depends on the level of research funding, which can be influenced by government budgets and economic cycles.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Harvard Bioscience
Harvard Bioscience produces a wide range of equipment for biomedical research. The chart shows future revenue expectations, which depend on research budgets at universities, pharmaceutical companies, and government laboratories. This is a bet on stable growth in scientific activity.
Future (projected) P/E of the market segment - Medical instruments
Harvard Bioscience produces and sells a wide range of instruments and equipment for biomedical research. This chart shows how its future profit expectations compare to the industry average. Does this valuation reflect its role as a supplier of foundational tools for scientific discovery?
Future (projected) P/E of the market as a whole
Harvard Bioscience produces a wide range of laboratory equipment for biomedical research. Demand for its products depends on the research budgets of universities and pharmaceutical companies. These budgets are more stable than corporate profits, giving the company stability.
Profit of the company, segment and market as a whole
Company profit Harvard Bioscience
Harvard Bioscience develops, manufactures, and sells equipment and instruments for biomedical research. The company's profits depend on research expenditures from universities, pharmaceutical companies, and biotech companies. This chart shows how the level of research funding and the pace of innovation in biotechnology influence the demand for its products.
Profit of companies in the market segment - Medical instruments
Harvard Bioscience, Inc. is a developer and manufacturer of instruments and equipment for biomedical research. This chart shows the profitability of the medical instruments sector. The company's products are used in academic laboratories and pharmaceutical companies. Demand for them is an indicator of investment in scientific research and drug development.
Overall market profit
Harvard Bioscience produces a wide range of scientific equipment for biomedical research. Demand for its products depends on the budgets of universities, pharmaceutical companies, and public research institutes. These budgets, in turn, depend on the overall state of the economy, as reflected in this graph, and on government science funding priorities.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Harvard Bioscience
Harvard Bioscience produces a wide range of laboratory equipment and instruments for biomedical research. The future profit forecasts presented here depend on R&D spending by pharmaceutical companies, universities, and government laboratories. This indicator reflects analysts' assessment of the level of research funding.
Future (predicted) profit of companies in the market segment - Medical instruments
Harvard Bioscience, Inc. develops, manufactures, and markets equipment and supplies for biomedical research. This chart shows profitability forecasts for the medical instruments sector. It reflects research spending expectations from pharmaceutical companies and academic institutions.
Future (predicted) profit of the market as a whole
Harvard Bioscience produces scientific equipment for biomedical research. Demand for its products depends on scientific funding and pharmaceutical companies' R&D budgets. The projected growth in overall market revenue indicates that its clients will have the funds for new research, which is a driver for Harvard Bioscience.
P/S of the company, segment and market as a whole
P/S - Harvard Bioscience
Harvard Bioscience produces a wide range of laboratory equipment for biomedical research. Its revenue is dependent on the budgets of scientific institutions and pharmaceutical companies. The P/S ratio reflects how investors view its diversified product portfolio and the stability of demand for scientific instruments.
P/S market segment - Medical instruments
Harvard Bioscience manufactures and sells a wide range of instruments and equipment for biomedical research used in academic laboratories and pharmaceutical companies. Their revenue is driven by research budgets. This chart shows how the market values ββtheir product portfolio and position in the laboratory equipment market.
P/S of the market as a whole
Harvard Bioscience manufactures and sells a wide range of laboratory equipment for biomedical research. The company's revenue is dependent on the budgets of scientific and pharmaceutical organizations. This chart shows the average revenue estimate, which helps understand how the market values ββthe income of a stable supplier to the research-intensive industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Harvard Bioscience
Harvard Bioscience manufactures and sells a wide range of scientific equipment and instruments for life science research. This chart shows how investors estimate future sales, which depend on the level of research funding at universities, biotech companies, and pharmaceutical companies worldwide.
Future (projected) P/S of the market segment - Medical instruments
Harvard Bioscience, Inc. develops, manufactures, and markets equipment, instruments, and consumables for biomedical research. This chart shows how the market estimates its future sales to laboratories and research institutions. It compares it to other medical instrument manufacturers, reflecting the level of funding for science and research.
Future (projected) P/S of the market as a whole
Harvard Bioscience produces a wide range of scientific equipment and laboratory tools used in life science research. Demand for its products depends on scientific funding. This chart illustrates general expectations for future revenue, and HBIO shows how companies providing the infrastructure for scientific discovery are growing alongside progress.
Sales of the company, segment and market as a whole
Company sales Harvard Bioscience
Harvard Bioscience is a global developer, manufacturer, and marketer of life sciences research equipment and instruments. This chart shows revenue from a wide range of products, from syringe pumps to cell and molecular biology systems used in academic and pharmaceutical laboratories.
Sales of companies in the market segment - Medical instruments
Harvard Bioscience manufactures and sells a wide range of scientific equipment for biomedical research. This chart segments its revenue, showing revenue from cellular and molecular technologies versus preclinical research products. This reflects its focus on different stages of scientific research.
Overall market sales
Harvard Bioscience produces a wide range of instruments and equipment for biomedical research. Demand for its products depends on research budgets at universities, pharmaceutical companies, and government agencies. These budgets are generally stable, making the company's business less cyclical than this chart suggests.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Harvard Bioscience
Harvard Bioscience produces a wide range of scientific equipment and instruments for life science research. The company's revenue forecast depends on research budgets at universities and pharmaceutical companies. This chart shows analysts' estimates of demand for laboratory equipment.
Future (projected) sales of companies in the market segment - Medical instruments
Harvard Bioscience develops, manufactures, and sells equipment and instruments for biomedical research. This chart shows projected revenues for the entire medical instruments sector. It allows one to estimate the level of research funding, which directly impacts demand for Harvard Bioscience products from laboratories and universities.
Future (projected) sales of the market as a whole
Harvard Bioscience produces a wide range of scientific equipment and instruments for life science research. Demand for its products depends on R&D budgets at universities, biotech companies, and government laboratories. This business activity forecast chart reflects the company's commitment to investing in science, a key driver.
Marginality of the company, segment and market as a whole
Company marginality Harvard Bioscience
Harvard Bioscience manufactures and sells a wide range of instruments and equipment for biomedical research. This chart shows how the company serves the scientific community. Its profitability depends on the level of funding for science and R&D, which directly impacts demand for its products from laboratories and universities.
Market segment marginality - Medical instruments
Harvard Bioscience is a global developer, manufacturer, and marketer of technologies, instruments, and products used to advance biomedical research. This chart shows the average profit margin in the scientific equipment sector. It helps assess how Harvard Bioscience's innovation and reputation impact its profitability relative to its competitors.
Market marginality as a whole
Harvard Bioscience, Inc. produces a wide range of equipment for life science research. Demand for its products depends on scientific funding and pharmaceutical companies' R&D budgets. This overall profitability chart indirectly reflects the willingness of corporations and governments to invest in scientific research.
Employees in the company, segment and market as a whole
Number of employees in the company Harvard Bioscience
Harvard Bioscience produces a wide range of scientific equipment for biomedical research. Its staff includes engineers, manufacturing personnel, and sales specialists. This chart reflects the scale of its diversified product portfolio and its role as a supplier of instruments to laboratories worldwide.
Share of the company's employees Harvard Bioscience within the market segment - Medical instruments
Harvard Bioscience, Inc. develops, manufactures, and markets a wide range of equipment and instruments for biomedical research. This chart shows its contribution to science. It reflects the percentage of engineers, biologists, and sales professionals who create and supply the equipment used by scientists in laboratories around the world who work at Harvard Bioscience.
Number of employees in the market segment - Medical instruments
Harvard Bioscience, Inc. develops, manufactures, and markets equipment and instruments for biomedical research. This chart shows overall employment in the medical instruments sector. Growth in this field reflects increased research funding and the continued need for advanced equipment in laboratories.
Number of employees in the market as a whole
Harvard Bioscience, Inc. is a developer, manufacturer, and marketer of equipment and instruments for biomedical research. Companies supplying scientific equipment are the foundation for future discoveries. This chart shows overall employment, and their growth reflects increased investment in R&D worldwide.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Harvard Bioscience (HBIO)
Harvard Bioscience produces scientific equipment. This is a business that requires high levels of engineering expertise. The metric on this chart reflects both the value of its brand and patents and the complexity of its equipment. It's an assessment of the company's ability to create instruments that advance science, measured per employee.
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
Harvard Bioscience produces scientific equipment for biomedical research. In this sector, market value per employee reflects brand strength, technology value, and production efficiency. Comparisons with competitors help understand the company's success in creating innovative tools for scientists.
Market capitalization per employee (in thousands of dollars) for the overall market
Harvard Bioscience produces a wide range of instruments and equipment for biomedical research. It's a business that provides scientists with the tools they need to make discoveries. This chart reflects how the market values ββthe company's ability to develop and manufacture reliable equipment for scientific laboratories worldwide.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Harvard Bioscience (HBIO)
Harvard Bioscience produces a wide range of highly specialized laboratory equipment for the life sciences used in R&D. It is a B2B business selling "tools for scientists." This chart shows how efficiently the company sells these niche instruments, generating profit from each engineer and salesperson.
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
Harvard Bioscience develops, manufactures, and markets a wide range of equipment and instruments for biomedical research. This chart is an indicator of their operational efficiency. It reflects how successfully the company transforms its engineering developments into profitable products in demand by scientists and laboratories worldwide in the competitive scientific instrumentation sector.
Profit per employee (in thousands of dollars) for the market as a whole
Harvard Bioscience produces a wide range of laboratory equipment and instruments for the life sciences. It is a manufacturing R&D business. This metric reflects how effectively the company manages its diverse product portfolio. It shows the balance between R&D and manufacturing costs and the profitability of its scientific equipment.
Sales to employees of the company, segment and market as a whole
Sales per company employee Harvard Bioscience (HBIO)
Harvard Bioscience, a manufacturer of biomedical research instruments, uses this chart to demonstrate the efficiency of its production and sales operations. Revenue per employee depends on the budgets of research laboratories and universities. An increase in this indicator indicates demand for its equipment and consumables.
Sales per employee in the market segment - Medical instruments
Harvard Bioscience (HBIO) manufactures and sells a wide range of laboratory equipment and instruments for life science research. This chart shows the average revenue per employee in this segment. Comparing HBIO to this benchmark helps assess how effectively their R&D and sales teams sell specialized equipment to scientific laboratories.
Sales per employee for the market as a whole
Harvard Bioscience (HBIO) produces a wide range of laboratory equipment for biomedical research. It's a classic instrumentation business. This metric reflects the demand for their instruments (syringe pumps, spectrometers) among scientists. Growth indicates successful R&D and efficient manufacturing.
Short shares by company, segment and market as a whole
Shares shorted by company Harvard Bioscience (HBIO)
Harvard Bioscience produces a wide range of laboratory equipment for biomedical research (syringe pumps, electrophysiology equipment). This chart shows the bets on a slowdown in science. "Bears" expect budget cuts in biotech and academia to lead to reduced demand for their scientific equipment.
Shares shorted by market segment - Medical instruments
Harvard Bioscience (HBIO) is a manufacturer of laboratory equipment for the life sciences. Its customers are biotech companies and universities. This chart shows the pessimism in the sector. The growing short position in the sector is a bet on a "biotech winter." Investors expect that, due to funding problems, small biotech companies and research institutes will freeze budgets and stop purchasing new equipment, which will hurt HBIO's sales.
Shares shorted by the overall market
Harvard Bioscience (HBIO) supplies laboratory equipment. These are the "shovels" for R&D. When this chart shows rising fear, it signals a "venture winter." This means that HBIO's clients (small biotech companies, universities) are freezing R&D and stopping purchasing equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Harvard Bioscience (HBIO)
Harvard Bioscience produces laboratory equipment for biomedical research. It was the "shovel supplier" during the biotech gold rush. This graph measures the "temperature" of R&D spending. It "heats up" when biotech companies and universities are actively spending on equipment and "cools down" when budgets are cut.
RSI 14 Market Segment - Medical instruments
Harvard Bioscience is a manufacturer of scientific tools and equipment. They supply specialized equipment (syringe pumps, cell research systems) for laboratories and R&D. This chart reflects the overall sentiment in the medical instrumentation sector. It helps assess whether the entire sector is overheated due to demand from the scientific community.
RSI 14 for the overall market
Harvard Bioscience (HBIO) is a "supplier" for biotech companies. This chart shows the "health" of its clients. In the euphoria, biotech companies easily attract capital and actively pursue R&D, buying up HBIO equipment. In a panic, R&D funding dries up, biotech companies "freeze" research, and demand for scientific consumables falls.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast HBIO (Harvard Bioscience)
Harvard Bioscience is a manufacturer of laboratory equipment (instruments, pumps, and systems) for preclinical research in the life sciences. This chart shows the average 12-month price target from analysts, reflecting their view of the R&D budgets of pharmaceutical companies and academic labs.
The difference between the consensus estimate and the actual stock price HBIO (Harvard Bioscience)
Harvard Bioscience is a manufacturer and supplier of scientific equipment for preclinical research in life sciences (e.g., cellular physiology). This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their views on R&D budgets in the pharmaceutical and academic sectors.
Analyst consensus forecast for stock prices by market segment - Medical instruments
Harvard Bioscience is a "weapons supplier" for science. The company produces laboratory equipment (syringe pumps, cell research systems) essential for pharmaceutical R&D. This chart shows general expectations for the medical instruments sector. It reflects whether experts believe R&D budgets in biotech will grow.
Analysts' consensus forecast for the overall market share price
Harvard Bioscience is not a university, but a manufacturer of laboratory equipment (syringe pumps, spectrometers, cell therapy equipment) for the life sciences sector. This chart shows the overall market sentiment. For Harvard Bioscience, whose business depends on R&D spending, the analysts' overall optimism is a direct signal of the willingness of pharmaceutical companies and universities to equip their laboratories.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Harvard Bioscience
Harvard Bioscience is an R&D toolbox. They don't make drugs; they produce lab equipment (syringe pumps, cell systems, spectrometers) used by scientists at universities and biotech companies. This chart is a barometer of R&D spending. It reflects their lumpy order book, which depends on scientific funding cycles.
AKIMA Market Segment Index - Medical instruments
Harvard Bioscience (HBIO) is a global supplier of laboratory equipment. They produce a wide range of instruments (syringe pumps, spectrometers) for preclinical research in the life sciences. The chart shows the average index for the segment. It helps investors assess how HBIO, as a supplier of picks and shovels to science, compares to the average.
The AKIM Index for the overall market
Harvard Bioscience is a developer and manufacturer of specialized scientific equipment and instruments for biological research. This chart, reflecting the market average, is a backdrop. It helps assess how HBIO, which depends on laboratory and pharmaceutical budgets, compares to general macroeconomic fluctuations.